Genomics

Dataset Information

0

The impact of BNT162b2 mRNA vaccine against SARS-CoV-2 on adaptive and innate immune responses


ABSTRACT: The mRNA-based BNT162b2 protects against severe disease and mortality caused by SARS-CoV-2 through induction of specific antibody and T-cell responses. Much less is known about its broad effects on immune responses against other pathogens. In the present study, we investigated the specific adaptive immune responses induced by BNT162b2 vaccination against various SARS-CoV-2 variants, as well as its effects on the responsiveness of human immune cells upon stimulation with heterologous viral, bacterial, and fungal pathogens. BNT162b2 vaccination induced effective humoral and cellular immunity against SARS-CoV-2 that started to wane after six months. We also observed long-term transcriptional changes in immune cells after vaccination, as assessed by RNA sequencing. Additionally, vaccination with BNT162b2 modulated innate immune responses as measured by the production of inflammatory cytokines when stimulated with various microbial stimuli other than SARS-CoV-2, including higher IL-1/IL-6 release and decreased production of IFN-α. Altogether, these data expand our knowledge regarding the overall immunological effects of this new class of vaccines and underline the need of additional studies to elucidate their effects on both innate and adaptive immune responses.

PROVIDER: EGAS00001006818 | EGA |

REPOSITORIES: EGA

Similar Datasets

2022-05-02 | GSE200274 | GEO
2024-04-18 | E-MTAB-13721 | biostudies-arrayexpress
2022-05-20 | GSE201535 | GEO
2010-02-24 | E-GEOD-17400 | biostudies-arrayexpress
2024-03-01 | GSE250024 | GEO
2024-03-01 | GSE250023 | GEO
2024-03-04 | GSE260763 | GEO
2021-03-20 | E-MTAB-10169 | biostudies-arrayexpress
2024-09-18 | GSE253635 | GEO
2022-05-04 | GSE193288 | GEO